Andrew T.L. Ong

8.4k total citations · 3 hit papers
66 papers, 6.0k citations indexed

About

Andrew T.L. Ong is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Andrew T.L. Ong has authored 66 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Surgery, 44 papers in Cardiology and Cardiovascular Medicine and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Andrew T.L. Ong's work include Coronary Interventions and Diagnostics (48 papers), Acute Myocardial Infarction Research (22 papers) and Cardiac Imaging and Diagnostics (18 papers). Andrew T.L. Ong is often cited by papers focused on Coronary Interventions and Diagnostics (48 papers), Acute Myocardial Infarction Research (22 papers) and Cardiac Imaging and Diagnostics (18 papers). Andrew T.L. Ong collaborates with scholars based in Netherlands, Australia and United States. Andrew T.L. Ong's co-authors include Patrick W. Serruys, Eugène McFadden, Evelyn Regar, Ron T. van Domburg, Michael J.B. Kutryk, Willem J. van der Giessen, Jiro Aoki, Peter P.T. de Jaegere, Georgios Sianos and Pim J. de Feyter and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Andrew T.L. Ong

63 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy

2004 1.0k citations Eugène McFadden, Eugenio Stabile et al. The Lancet profile →
Coronary-Artery Stents

2006 537 citations Patrick W. Serruys, Michael J.B. Kutryk et al. New England Journal of Medicine profile →
Late Angiographic Stent Thrombosis (LAST) Events With Drug-Eluting Stents

2005 528 citations Andrew T.L. Ong, Eugène McFadden et al. Journal of the American College of Cardiology profile →

Peers

Countries citing papers authored by Andrew T.L. Ong

Since Specialization

Citations

This map shows the geographic impact of Andrew T.L. Ong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew T.L. Ong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew T.L. Ong more than expected).

Fields of papers citing papers by Andrew T.L. Ong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew T.L. Ong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew T.L. Ong. The network helps show where Andrew T.L. Ong may publish in the future.

Co-authorship network of co-authors of Andrew T.L. Ong

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew T.L. Ong. A scholar is included among the top collaborators of Andrew T.L. Ong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew T.L. Ong. Andrew T.L. Ong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Predictive Value of ST Resolution Analysis Performed Immediately Versus at Ninety Minutes After Primary Percutaneous Coronary Intervention 2010 ·The American Journal of Cardiology ·Saurabh Kumar, Gopal Sivagangabalan, (unknown), Alisdair Ryding, Arun Narayan, (unknown), David Burgess, Andrew T.L. Ong, Norman Sadick, Pramesh Kovoor	5
2	Prognostic Impact of Q Waves on Presentation and ST Resolution in Patients With ST-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention 2009 ·The American Journal of Cardiology ·Saurabh Kumar, (unknown), Gopal Sivagangabalan, (unknown), Alisdair Ryding, Arun Narayan, Andrew T.L. Ong, Norman Sadick, Pramesh Kovoor	10
3	Medication Adherence Self-report Instruments 2008 ·The Journal of Cardiovascular Nursing ·John Rolley, Patricia M. Davidson, Cheryl Dennison Himmelfarb, Andrew T.L. Ong, Bronwyn Everett, Yenna Salamonson	29
4	Risk factors for impaired health status differ in women and men treated with percutaneous coronary intervention in the drug-eluting stent era 2006 ·Journal of Psychosomatic Research ·Susanne S. Pedersen, Andrew T.L. Ong, Pedro A. Lemos, Ruud A.M. Erdman, Patrick W. Serruys, Ron T. van Domburg	6
5	Anxiety enhances the detrimental effect of depressive symptoms on health status following percutaneous coronary intervention 2006 ·Journal of Psychosomatic Research ·Susanne S. Pedersen, Johan Denollet, Helle Spindler, Andrew T.L. Ong, Patrick W. Serruys, Ruud A.M. Erdman, Ron T. van Domburg	39
6	Sirolimus-Eluting Versus Paclitaxel-Eluting Stent Implantation for the Percutaneous Treatment of Left Main Coronary Artery Disease 2006 ·Journal of the American College of Cardiology ·Marco Valgimigli, Patrizia Malagutti, Jiro Aoki, Héctor M. García‐García, Gastón A. Rodríguez-Granillo, Carlos A.G. van Mieghem, Jürgen Ligthart, Andrew T.L. Ong, George Sianos, Evelyn Regar, Ron T. van Domburg, Pim de Feyter, Peter de Jaegere, Patrick W. Serruys	67
7	Guidewire navigation in coronary artery stenoses using a novel magnetic navigation system: First clinical experience 2006 ·Catheterization and Cardiovascular Interventions ·Keiichi Tsuchida, Héctor M. García‐García, Willem J. van der Giessen, Eugène McFadden, Martin van der Ent, Georgios Sianos, (unknown), Andrew T.L. Ong, Patrick W. Serruys	40
8	Coronary-Artery Stents breakdown → 2006 ·New England Journal of Medicine ·Patrick W. Serruys, Michael J.B. Kutryk, Andrew T.L. Ong	537
9	Five-Year Outcomes After Coronary Stenting Versus Bypass Surgery for the Treatment of Multivessel Disease 2005 ·Journal of the American College of Cardiology ·Patrick W. Serruys, Andrew T.L. Ong, Lex A. van Herwerden, J. Eduardo Sousa, Adib Jatene, J. J. R. M. Bonnier, (unknown), Nigel Buller, Robert S. Bonser, Clemens Disco, Bianca Backx, Paul G. Hugenholtz, Brian G. Firth, Felix Unger	428
10	Evaluation of Four-Year Coronary Artery Response After Sirolimus-Eluting Stent Implantation Using Serial Quantitative Intravascular Ultrasound and Computer-Assisted Grayscale Value Analysis for Plaque Composition in Event-Free Patients 2005 ·Journal of the American College of Cardiology ·Jiro Aoki, Alexandre Abizaid, Patrick W. Serruys, Andrew T.L. Ong, Eric Boersma, J. Eduardo Sousa, Nico Bruining	74
11	Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents 2005 ·The American Journal of Cardiology ·Pedro A. Lemos, Chourmouzios A. Arampatzis, Angela Hoye, Joost Daemen, Andrew T.L. Ong, Francesco Saia, Willem J. van der Giessen, Eugène McFadden, Georgios Sianos, Pieter C. Smits, Pim de Feyter, Sjoerd H. Hofma, Ron T. van Domburg, Patrick W. Serruys	81
12	Drug‐Eluting Stents for Interventional Revascularization of Coronary Multivessel Disease 2005 ·Journal of Interventional Cardiology ·Andrew T.L. Ong, Willem J. van der Giessen	5
13	Endothelial Progenitor Cell Capture by Stents Coated With Antibody Against CD34 2005 ·Journal of the American College of Cardiology ·Jiro Aoki, Patrick W. Serruys, Heleen van Beusekom, Andrew T.L. Ong, Eugène McFadden, Georgios Sianos, Willem J. van der Giessen, Evelyn Regar, Pim J. de Feyter, H. Davis, Stephen Rowland, Michael J.B. Kutryk	425
14	Technology Insight: an overview of research in drug-eluting stents 2005 ·Nature Clinical Practice Cardiovascular Medicine ·Andrew T.L. Ong, Patrick W. Serruys	46
15	Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation 2005 ·Journal of the American College of Cardiology ·Andrew T.L. Ong, Angela Hoye, Jiro Aoki, Carlos A.G. van Mieghem, Gastón A. Rodríguez-Granillo, Karel Sonnenschein, Evelyn Regar, Eugène McFadden, Georgios Sianos, Willem J. van der Giessen, Peter P.T. de Jaegere, Pim de Feyter, Ron T. van Domburg, Patrick W. Serruys	325
16	Five year clinical effect of coronary stenting and coronary artery bypass grafting in renal insufficient patients with multivessel coronary artery disease: insights from ARTS trial 2005 ·European Heart Journal ·Jiro Aoki, Andrew T.L. Ong, Angela Hoye, Lex A. van Herwerden, J. Eduardo Sousa, Adib Jatene, J. J. R. M. Bonnier, (unknown), Nigel Buller, Robert S. Bonser, Wietze Lindeboom, Felix Unger, Patrick W. Serruys	46
17	“Full metal jacket” (stented length ≥64 mm) using drug-eluting stents for de novo coronary artery lesions 2005 ·American Heart Journal ·Jiro Aoki, Andrew T.L. Ong, Gastón A. Rodríguez-Granillo, Eugène McFadden, Carlos A.G. van Mieghem, Marco Valgimigli, Keiichi Tsuchida, Georgios Sianos, Evelyn Regar, Peter P.T. de Jaegere, Willem J. van der Giessen, Pim J. de Feyter, Ron T. van Domburg, Patrick W. Serruys	57
18	Late Angiographic Stent Thrombosis (LAST) Events With Drug-Eluting Stents breakdown → 2005 ·Journal of the American College of Cardiology ·Andrew T.L. Ong, Eugène McFadden, Evelyn Regar, Peter P.T. de Jaegere, Ron T. van Domburg, Patrick W. Serruys	528
19	Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction 2004 ·Journal of the American College of Cardiology ·Pedro A. Lemos, Francesco Saia, Sjoerd H. Hofma, Joost Daemen, Andrew T.L. Ong, Chourmouzios A. Arampatzis, Angela Hoye, Eugène McFadden, Georgios Sianos, Pieter C. Smits, Willem J. van der Giessen, Pim de Feyter, Ron T. van Domburg, Patrick W. Serruys	135
20	Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy breakdown → 2004 ·The Lancet ·Eugène McFadden, Eugenio Stabile, Evelyn Regar, Édouard Cheneau, Andrew T.L. Ong, Timothy Kinnaird, William O. Suddath, Neil J. Weissman, Rebecca Torguson, Kenneth M. Kent, August D Pichard, Lowell F. Satler, Ron Waksman, Patrick W. Serruys	1029

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact